166 related articles for article (PubMed ID: 17476512)
1. Markedly improving survival of neuroblastoma: a 30-year analysis of 1,646 patients.
Gutierrez JC; Fischer AC; Sola JE; Perez EA; Koniaris LG
Pediatr Surg Int; 2007 Jul; 23(7):637-46. PubMed ID: 17476512
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Incidence and Outcomes of Neuroblastoma in Children, Adolescents, and Adults in the United States: A Surveillance, Epidemiology, and End Results (SEER) Program Population Study.
Yan P; Qi F; Bian L; Xu Y; Zhou J; Hu J; Ren L; Li M; Tang W
Med Sci Monit; 2020 Nov; 26():e927218. PubMed ID: 33249420
[TBL] [Abstract][Full Text] [Related]
3. Incidence, survival, and prevalence of neuroendocrine tumors versus neuroblastoma in children and young adults: nine standard SEER registries, 1975-2006.
Navalkele P; O'Dorisio MS; O'Dorisio TM; Zamba GK; Lynch CF
Pediatr Blood Cancer; 2011 Jan; 56(1):50-7. PubMed ID: 21108439
[TBL] [Abstract][Full Text] [Related]
4. Persisting inequalities in survival patterns of childhood neuroblastoma in Southern and Eastern Europe and the effect of socio-economic development compared with those of the US.
Panagopoulou P; Georgakis MK; Baka M; Moschovi M; Papadakis V; Polychronopoulou S; Kourti M; Hatzipantelis E; Stiakaki E; Dana H; Tragiannidis A; Bouka E; Antunes L; Bastos J; Coza D; Demetriou A; Agius D; Eser S; Gheorghiu R; Šekerija M; Trojanowski M; Žagar T; Zborovskaya A; Ryzhov A; Dessypris N; Morgenstern D; Petridou ET
Eur J Cancer; 2018 Jun; 96():44-53. PubMed ID: 29673989
[TBL] [Abstract][Full Text] [Related]
5. Improved survival of children with neuroblastoma between 1979 and 2005: a report of the Italian Neuroblastoma Registry.
Haupt R; Garaventa A; Gambini C; Parodi S; Cangemi G; Casale F; Viscardi E; Bianchi M; Prete A; Jenkner A; Luksch R; Di Cataldo A; Favre C; D'Angelo P; Zanazzo GA; Arcamone G; Izzi GC; Gigliotti AR; Pastore G; De Bernardi B
J Clin Oncol; 2010 May; 28(14):2331-8. PubMed ID: 20351331
[TBL] [Abstract][Full Text] [Related]
6. Risk of developing second malignant neoplasms in patients with neuroblastoma: a population study of the US SEER database.
Zhen H; Guan H; Ma J; Wang W; Jing S; Miao Z; Zhang F; Liu Z
Radiat Oncol; 2021 Nov; 16(1):228. PubMed ID: 34838090
[TBL] [Abstract][Full Text] [Related]
7. The who, when, and why of primary adrenal malignancies: Insights into the epidemiology of a rare clinical entity.
Chandrasekar T; Goldberg H; Klaassen Z; Wallis CJD; Woon DTS; Herrera-Caceres JO; Kulkarni GS; Fleshner NE
Cancer; 2019 Apr; 125(7):1050-1059. PubMed ID: 30561782
[TBL] [Abstract][Full Text] [Related]
8. Incidence, Treatment, and Survival in Primary Central Nervous System Neuroblastoma.
Lu X; Zhang X; Deng X; Yang Z; Shen X; Sheng H; Yin B; Zhang N; Lin J
World Neurosurg; 2020 Aug; 140():e61-e72. PubMed ID: 32344130
[TBL] [Abstract][Full Text] [Related]
9. The effect of age distribution on the prognosis of retroperitoneal neuroblastoma.
Liu X; Zhao J; Zhang L; Huang J; Ma Y
Medicine (Baltimore); 2020 Jun; 99(23):e20639. PubMed ID: 32502048
[TBL] [Abstract][Full Text] [Related]
10. Neuroblastoma in Turkish children: experience of a single center.
Aydn GB; Kutluk MT; Yalçn B; Büyükpamukçu M; Kale G; Varan A; Akyüz C; Senocak ME; Büyükpamukçu N
J Pediatr Hematol Oncol; 2009 Jul; 31(7):471-80. PubMed ID: 19564739
[TBL] [Abstract][Full Text] [Related]
11. Neuroblastoma in adults: Incidence and survival analysis based on SEER data.
Esiashvili N; Goodman M; Ward K; Marcus RB; Johnstone PA
Pediatr Blood Cancer; 2007 Jul; 49(1):41-6. PubMed ID: 16628557
[TBL] [Abstract][Full Text] [Related]
12. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children's Oncology Group study.
Nuchtern JG; London WB; Barnewolt CE; Naranjo A; McGrady PW; Geiger JD; Diller L; Schmidt ML; Maris JM; Cohn SL; Shamberger RC
Ann Surg; 2012 Oct; 256(4):573-80. PubMed ID: 22964741
[TBL] [Abstract][Full Text] [Related]
14. Pediatric Patients with Adrenal Neuroblastoma: A SEER Analysis, 2004-2013.
Chen S; Tang W; Yang R; Hu X; Li Z
Am Surg; 2020 Feb; 86(2):127-133. PubMed ID: 32167055
[TBL] [Abstract][Full Text] [Related]
15. Increasing incidence of neuroblastoma and potentially higher associated mortality of children from nonmetropolitan areas: analysis of the surveillance, epidemiology, and end results database.
Hsieh MH; Meng MV; Walsh TJ; Matthay KK; Baskin LS
J Pediatr Hematol Oncol; 2009 Dec; 31(12):942-6. PubMed ID: 19875967
[TBL] [Abstract][Full Text] [Related]
16. Overall survival for neuroblastoma in South Africa between 2000 and 2014.
Van Heerden J; Hendricks M; Geel J; Sartorius B; Hadley GP; Du Plessis J; Büchner A; Naidu G; Van Emmenes B; Van Zyl A; Kruger M
Pediatr Blood Cancer; 2019 Nov; 66(11):e27944. PubMed ID: 31368239
[TBL] [Abstract][Full Text] [Related]
17. Factors Associated With the Improved Survival of Head and Neck Neuroblastomas Compared to Other Body Sites.
Kaufmann MR; Camilon PR; Janz TA; Levi JR
Ann Otol Rhinol Laryngol; 2019 Mar; 128(3):241-248. PubMed ID: 30565471
[TBL] [Abstract][Full Text] [Related]
18. Incidence and outcomes of malignant pediatric lung neoplasms.
Neville HL; Hogan AR; Zhuge Y; Perez EA; Cheung MC; Koniaris LG; Thompson WR; Sola JE
J Surg Res; 2009 Oct; 156(2):224-30. PubMed ID: 19631347
[TBL] [Abstract][Full Text] [Related]
19. Screening for neuroblastoma: a review of the evidence.
Chamberlain J
J Med Screen; 1994 Jul; 1(3):169-75. PubMed ID: 8790511
[TBL] [Abstract][Full Text] [Related]
20. Predictors of survival and incidence of hepatoblastoma in the paediatric population.
Allan BJ; Parikh PP; Diaz S; Perez EA; Neville HL; Sola JE
HPB (Oxford); 2013 Oct; 15(10):741-6. PubMed ID: 23600968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
